Ablexis
San Francisco · Founded 2009
About Ablexis
Ablexis, LLC, a biotechnology company dedicated to developing an innovative, next-generation platform for antibody drug discovery, was founded in December 2009, based on technology principles established by its subsidiary, Aliva Biopharmaceuticals, Inc.
Company Facts
- Founded: 2009
- Legal name: Ablexis, LLC
- Operating status: Acquired
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $12.0M
- Funding stage: M&A
- Last round: Series A (Jun 2010)
- Website: ablexis.com
- Phone: (415) 967-1220
Social Profiles
Canonical: https://fsome.com/organization/ablexis-8355137 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.